Ligase Targeting Drug Development Summit

As the therapeutic value of manipulating previously hard-to-drug ubiquitin ligases becomes more and more evident in addressing numerous diseases with .. Read more unmet clinical needs, the inaugural Ligase Targeting Drug Development Summit arrives as the dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to seize the day. Built with large pharma and biotech insight, the Ligase Targeting Drug Development Summit is fully dedicated to enabling novel ligase discovery and characterization, achieving cell and tissue specificity and expanding chemical biology tools to therapeutically leverage ubiquitin ligases for effective protein modulation or degradation strategies. As leading pharma companies join forces to bridge the gap between the functional knowledge and true translational value of ubiquitin ligases and their associated ligands, join us to advance your understanding, differentiate your pipelines and tap into the uncapped therapeutic potentials of this emerging field.